CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

From TechCrunch

By Dominic-Madori Davis

October 5, 2025

Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

Dr. Tom Kelly is a trauma surgeon, and everywhere, he sees doctors drowning in administrative work. He wanted change, so he set out to build it. 

“We wanted to build an AI care partner that would stand alongside clinicians and take care of the admin so that individual providers, like me, can feel empowered to deliver the care which we dedicated our lives to,” he told TechCrunch. 

Dr. Kelly teamed up with Waleed Mussa, with whom he had worked at a previous startup, and founded Heidi Health in 2021. The company began launching products in early 2024. 

In just 18 months, he said, the company has returned more than “18 million hours to frontline healthcare providers from more than 70 million patient visits in 116 countries.” 

The product, as promised, is an AI medical scribe that takes care of all the admin work that hassles doctors. It can transcribe and dictate notes, generate personalized patient summaries, and even track tasks so doctors no longer have a need for sticky notes. 

Heidi both built its own AI model and builds on top of other models, such as Gemini. “This model-agnostic approach means that we can optimize our accuracy, latency, and cost,” he said. 

On Monday, the company announced a $65 million Series B led by Steve Cohen’s Point72 Private Investments. It also announced a new tool: an AI agent that calls patients on behalf of the doctor. The former chief medical officer at Microsoft, Dr. Simon Kos, is also coming on board, along with Plaid’s head of revenue, Paul Williamson. 

The company has raised $96.6 million to date. Others in the round include Headline, Blackbird VC, Possible Ventures, and Archangel.

“They had seen all the scribes before,” Dr. Kelly said of Point72 Private Investments. “They’d never seen product adoption and usage metrics like they’d seen in Heidi. They also loved that we were obsessed about the end user experience, because they saw most of our competitors were just doing top-down sales.” 

The fresh capital will be used to help with product development. 

Dr. Kelly hopes that giving doctors more access to AI tools will expand the capabilities of clinicians and remove the “drudgery” of their work. 

He said most of the conversations in the medical world right now are shaped by what is happening in developed countries, “but imagine a world where any healthcare provider in the world can use Heidi to increase their clinical capacity, where they can practice in a war zone, or a refugee camp, or a region hit by climate change or simply an underserved community,” he continued. “Heidi can help them reach more patients and deliver better healthcare results.”  

AI is transforming health tech. Others in the medical scribe space, in particular, include DeepScribe, Ambience Healthcare, and Abridge. 

Heidi said it works with more than 2 million clinicians a week, ranging from hospitals to individual practices. It has a free version of the product with paid features, which Dr. Kelly believes has been a good lure for new customers. 

He said AI is understandably going to change everything in healthcare. But at its core, humanity is still very essential, especially when it comes to maintaining and building trust. 

“It’s about doubling the world’s healthcare capacity. That’s the true promise of AI,” he said. “We want to bring it about.” 

This story was updated to clarify that the investment came from Point72 Private Investments and clarify the investors.

View original article on techcrunch.com

Most Recent

Chip legend Jim Keller’s Tenstorrent raises $1.5B to expand its open compute ecosystem

Artificial intelligence computing hardware startup Tenstorrent Inc. is pushing hard to position itself as an alternative to Nvidia Corp.’s graphics processing units after raising a massive $1.5 billion in a late-stage funding round today. The Series E round was jointly led by Trace Capital and Innov

Oct 19, 2026

Pax8 launches 8os to let IT partners govern AI agents and 8bot as a managed AI co-worker

Small business software marketplace Pax8 Inc. today launched 8os, an operating system that lets its information technology service provider partners govern the artificial intelligence agents running inside their customers’ businesses. A second product, 8bot, gives those customers’ employees a manage

Oct 19, 2026

Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics

Even Healthcare reaches a $300 million valuation in a Khosla Ventures-led round as it plans to expand its hospital network in India.

Oct 19, 2026

DeepSeek releases updated V4.1-Flash model it says completes tasks faster

Chinese artificial intelligence startup Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co. Ltd. has released an updated version of its V4.1-Flash model that it says completes tasks faster. DeepSeek-V4.1-Flash-1017 arrives a little over five weeks after the company launched the o

Oct 18, 2026

Similar Posts

Heidi Health nabs $340M to deepen adoption of AI agents within health systems globally

Heidi Health Trading Pty Ltd., a healthcare artificial intelligence startup, today announced it has raised a total of $340 million in new funding to support the company’s next phase of growth and deepen adoption throughout health systems. The funding comes from a combination of a $100 million Series

Sep 22, 2026

Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician

Heidi announced the closing of a $65 million Series B round led by Point72 Private Investments, with participation from Blackbird, Headline, and Latitude. The round values Heidi at $465 million and brings total funding to nearly $100 million.

Oct 5, 2025

Acrew Capital hits five years, raises $700M

Acrew Capital has raised $700 million in fresh funds. The San Francisco-based venture capital firm announced in a blog post on Thursday that it raised $700 million to invest in companies building in data and security, healthcare, or fintech. This fundraise brings the firm’s assets under management to $1.7 billion. It’s unclear how much of the $700 million will go to the firm’s early-stage strategy, which invests $1 million to $15 million into seed and Series A companies, and how much will go fo

Oct 18, 2024

AI Startup Heidi Hits $900 Million Valuation With New Investment Round

Australian healthcare AI startup Heidi raised $340M, including a $100M Series C led by Blackbird at a $900M valuation, taking its total funding to $430M+ — Heidi, an artificial intelligence startup which helps doctors automate clinical notes and other administrative work …

Sep 22, 2026